Intervention Review

Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)

  1. Nicole Bergner1,
  2. Ina Monsef1,
  3. Gerald Illerhaus2,
  4. Andreas Engert1,
  5. Nicole Skoetz1,*

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 31 MAY 2012

DOI: 10.1002/14651858.CD009355.pub2


How to Cite

Bergner N, Monsef I, Illerhaus G, Engert A, Skoetz N. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD009355. DOI: 10.1002/14651858.CD009355.pub2.

Author Information

  1. 1

    University Hospital of Cologne, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, Cologne, Germany

  2. 2

    University Hospital of Freiburg, Department I of Internal Medicine, Freiburg, Germany

*Nicole Skoetz, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. nicole.skoetz@uk-koeln.de.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Khê Hoang-Xuan, Eric Bessell, Jacoline Bromberg, Andreas F Hottinger, Matthias Preusser, Roberta Rudà, Uwe Schlegel, Tali Siegal, Carole Soussain, Ufuk Abacioglu, Nathalie Cassoux, Martina Deckert, Clemens M F Dirven, Andrés J M Ferreri, Francesc Graus, Roger Henriksson, Ulrich Herrlinger, Martin Taphoorn, Riccardo Soffietti, Michael Weller, Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology, The Lancet Oncology, 2015, 16, 7, e322

    CrossRef